DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical
Drug Delivery Market by Route and Application – Global Forecast to 2023”
report has been added to ResearchAndMarkets.com’s
offering.
The global pharmaceutical drug delivery market is projected to reach USD
1,694.7 billion by 2023 from USD 1,244.4 billion in 2018, at a CAGR of
6.4% during the forecast period.
Growth in this market is mainly driven by the rising prevalence of
chronic diseases, growth in the biologics market, and technological
advancements and new product launches. On the other hand, the risk of
needlestick injuries and the increasing pricing pressure are expected to
challenge market growth in the coming years.
“The home care settings segment is expected to grow at the
highest CAGR during the forecast period.”
Based on the facility of use, the pharmaceutical drug delivery market is
segmented hospitals, ambulatory surgical centres (ASCs)/clinics,
diagnostic centres, home care settings, and other facilities of use. The
home care settings segment is expected to grow at a higher CAGR during
the forecast period. This can majorly be attributed to increasing use of
various drug delivery devices such as injectables, nebulizers, and
inhalers in home care settings.
“The conventional injection devices segment accounted for
the largest share of the injectable drug delivery market in 2018.”
Based on the type, the injectable drug delivery technology is segmented
into conventional injection devices, self-injection devices, and other
devices. In 2018, conventional injection devices accounted for the
largest share of the injectable drug delivery technology market. The
large share of this segment can primarily be attributed to factors such
as the low cost of devices and manufacturing, large molecular size of
biologics administered through injectables, and the widespread
popularity of conventional devices.
“North America to dominate the market during the forecast
period.”
In 2018, North America accounted for the largest share of the
pharmaceutical drug delivery market. The large share of the North
American market is due to factors such as the rising prevalence of
chronic diseases such as cancer, respiratory allergies, and diabetes;
growth in biologics in the pharmaceuticals market; and the presence of a
large number of prominent players in this region.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Drug Delivery Technology: Market Overview
4.2 Drug Delivery Technology Market, By Route of Administration, 2018
Vs. 2023 (USD Billion)
4.3 Drug Delivery Technology Market, By Facility of Use, 2018-2023 (USD
Billion)
4.4 Drug Delivery Technology Market Share, By Application and Region,
2018
4.5 Drug Delivery Technology Market: Geographic Growth Opportunities
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 Rising Prevalence of Chronic Diseases
5.3.2 Growth in the Biologics Market
5.3.3 Technological Advancements and New Product Launches
5.4 Restraints
5.4.1 Risk of Needlestick Injuries
5.5 Opportunities
5.5.1 Self-Administration and Home Care
5.5.2 Rising Demand for Biosimilars
5.6 Challenges
5.6.1 Pricing Pressure
6 Drug Delivery Technology Market, By Route of Administration
6.1 Introduction
6.2 Oral Drug Delivery
6.2.1 Solid Oral Drugs
6.2.1.1 Tablets
6.2.1.2 Capsules
6.2.1.3 Powders
6.2.1.4 Pills
6.2.2 Liquid Oral Drugs
6.2.2.1 Syrups
6.2.2.2 Solutions
6.2.3 Semi-Solid Oral Drugs
6.2.3.1 Gels
6.2.3.2 Emulsions
6.2.3.3 Elixirs
6.3 Injectable Drug Delivery
6.3.1 Conventional Injection Devices
6.3.1.1 By Material
6.3.1.1.1 Glass
6.3.1.1.2 Plastic
6.3.1.2 By Product
6.3.1.2.1 Fillable Syringes
6.3.1.2.2 Prefilled Syringes
6.3.1.3 By Usability
6.3.1.3.1 Reusable Syringes
6.3.1.3.2 Disposable Syringes
6.3.2 Self-Injection Devices
6.3.2.1 Needle-Free Injectors
6.3.2.2 Autoinjectors
6.3.2.3 Pen Injectors
6.3.2.4 Wearable Injectors
6.3.3 Other Injector Devices
6.4 Topical Drug Delivery
6.4.1 Liquid Formulations
6.4.1.1 Solutions
6.4.1.2 Suspensions
6.4.2 Semi-Solid Formulations
6.4.2.1 Creams
6.4.2.2 Gels
6.4.2.3 Ointments
6.4.2.4 Pastes
6.4.2.5 Lotions
6.4.3 Solid Formulations
6.4.3.1 Suppositories
6.4.3.2 Powders
6.4.4 Transdermal Products
6.4.4.1 Transdermal Patches
6.4.4.2 Transdermal Gels
6.5 Ocular Drug Delivery
6.5.1 Liquid Formulations
6.5.1.1 Eye Drops
6.5.1.2 Liquid Sprays
6.5.2 Semi-Solid Formulations
6.5.2.1 Gels
6.5.2.2 Eye Ointments
6.5.3 Ocular Devices
6.5.3.1 Drug-Coated Contact Lenses
6.5.3.2 Ocular Inserts
6.6 Pulmonary Drug Delivery
6.6.1 Metered-Dose Inhalers
6.6.2 Dry Powder Inhalers
6.6.2.1 Dpi Drug Formulations are Chemically More Stable Than Their
Counterparts Are
6.6.3 Nebulizers
6.6.3.1 Jet Nebulizers
6.6.3.2 Ultrasonic Nebulizers
6.6.3.3 Soft Mist Nebulizers
6.7 Nasal Drug Delivery
6.7.1 Nasal Drops
6.7.2 Nasal Sprays
6.7.3 Nasal Powders
6.7.4 Nasal Gels
6.8 Transmucosal Drug Delivery
6.8.1 Oral Formulations
6.8.2 Other Transmucosal Drug Delivery Technologies
6.9 Implantable Drug Delivery
6.9.1 Active Implantable Drug Delivery
6.9.2 Passive Implantable Drug Delivery
7 Drug Delivery Technology Market, By Patient Care Setting
7.1 Introduction
7.2 Hospitals
7.2.1 Hospitals Will Continue to Dominate the Drug Delivery Technology
Market During the Forecast Period
7.3 Ambulatory Surgery Centers/Clinics
7.3.1 Increasing Preference for ASCS has Resulted in A Significant Rise
in Demand for Drug Delivery Technologies
7.4 Home Care Settings
7.4.1 Home Care Settings to Register the Highest Growth Rate During the
Forecast Period
7.5 Diagnostic Centers
7.5.1 Rising Prevalence of Chronic Diseases to Support Market Growth
7.6 Other Facilities of Use
8 Drug Delivery Technology Market, By Application
8.1 Introduction
8.2 Infectious Diseases
8.2.1 High Burden of Infectious Diseases Across the Globe to Drive
Market Growth
8.3 Cancer
8.3.1 Cancer Forms A Key Therapeutic Application Segment for Drug
Delivery Technologies
8.4 Cardiovascular Diseases
8.4.1 Increasing Prevalence of Cvds is Driving the Growth of the Drug
Delivery Technology Market
8.5 Diabetes
8.5.1 Emergence of New Technologies is Supporting Market Growth
8.6 Respiratory Diseases
8.6.1 High Prevalence of Asthma & Copd to Drive the Adoption of Drug
Delivery Technologies
8.7 Central Nervous System Disorders
8.7.1 Oral and Injectable Drug Delivery Systems are Widely Used in the
Treatment of Cns Disorders
8.8 Autoimmune Diseases
8.8.1 Autoimmune Diseases Segment to Register the Highest Growth in the
Forecast Period
8.9 Other Applications
8.9.1 Ophthalmic Disorders
8.9.2 Endocrine Disorders
9 Drug Delivery Technology Market, By Region
10 Competitive Landscape
10.1 Overview
10.2 Market Player Ranking, 2017
10.3 Competitive Scenario
10.4 Competitive Leadership Mapping (2017)
10.5 Competitive Leadership Mapping for Start-Ups (2017)
11 Company Profile
11.1 Johnson & Johnson Services, Inc.
11.2 Novartis AG
11.3 F. Hoffmann-La Roche Ltd.
11.4 Pfizer, Inc.
11.5 Bayer AG
11.6 Antares Pharma, Inc.
11.7 Becton, Dickinson and Company
11.8 GlaxoSmithKline PLC
11.9 3M
11.10 Merck & Co., Inc.
11.11 Sanofi
For more information about this report visit https://www.researchandmarkets.com/research/pgqh2q/1_69_bn?w=4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Drug
Delivery